Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 8/20 | 0.38 |
| ▸ | CA2 | P00918 | 8/20 | 0.38 |
| ▸ | CA9 | Q16790 | 7/20 | 0.38 |
| ▸ | LPAR3 | Q9UBY5 | 6/20 | 0.38 |
| ▸ | LPAR2 | Q9HBW0 | 5/20 | 0.38 |
| ▸ | CA12 | O43570 | 3/20 | 0.38 |
| ▸ | CA7 | P43166 | 3/20 | 0.38 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.38 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.38 |
| ▸ | CA3 | P07451 | 2/20 | 0.38 |
| ▸ | CA4 | P22748 | 2/20 | 0.38 |
| ▸ | CA6 | P23280 | 2/20 | 0.38 |
| ▸ | CA5A | P35218 | 2/20 | 0.38 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL980210 | 1.00 | THRB (0.42) | THRBTSHRMEN1HTTKMT2A | |
| SCHEMBL982824 | 1.00 | THRB (0.42) | THRBTSHRMEN1HTTKMT2A | |
| SCHEMBL983250 | 1.00 | THRB (0.42) | THRBTSHRMEN1HTTKMT2A | |
| SCHEMBL982044 | 1.00 | THRB (0.42) | THRBTSHRMEN1HTTKMT2A | |
| SCHEMBL984576 | 1.00 | THRB (0.42) | THRBTSHRMEN1HTTKMT2A | |
| SCHEMBL983446 | 1.00 | THRB (0.42) | THRBTSHRMEN1HTTKMT2A | |
| SCHEMBL134426 | 1.00 | THRB (0.42) | THRBTSHRMEN1HTTKMT2A | |
| SCHEMBL133829 | 1.00 | THRB (0.42) | THRBTSHRMEN1HTTKMT2A | |
| SCHEMBL982845 | 1.00 | THRB (0.42) | THRBTSHRMEN1HTTKMT2A | |
| SCHEMBL352666 | 1.00 | THRB (0.42) | THRBTSHRMEN1HTTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4161596-A1 | NANOFIBROUS MATERIAL PARTICULARLY FOR TOPICAL USE IN THERAPIES | Univerzita Karlova (CZ) | 2023-04-12 | — | — | EP | claimed |
| US-11135237-B2 | Lipophosphonoxins of second generation, and their use | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V.V.I. (CZ) | 2021-10-05 | — | — | US | claimed |
| US-20210220383-A1 | LIPOPHOSPHONOXINS OF SECOND GENERATION, AND THEIR USE | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V.V.I. (CZ) | 2021-07-22 | — | — | US | claimed |
| EP-3448865-B1 | LIPOPHOSPHONOXINS OF SECOND GENERATION, AND THEIR USE | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR V V I (CZ) | 2019-09-04 | — | — | EP | claimed |
| WO-2017186200-A1 | LIPOPHOSPHONOXINS OF SECOND GENERATION, AND THEIR USE | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V.V.I. (CZ) | 2017-11-02 | — | — | WO | claimed |
| EP-2527351-B1 | Lipophosphonoxins, method of their preparation and use | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR V V I (CZ) | 2013-12-11 | — | — | EP | claimed |
| CN-118302407-A | Carbonyl compound, method for producing isocyanate compound, and isocyanate composition | 旭化成株式会社 | 2024-07-05 | — | — | CN | disclosed |
| CN-118215651-A | Method for producing isocyanate compound, method for producing urethane compound, method for recovering amine compound, and isocyanate composition | 旭化成株式会社 | 2024-06-18 | — | — | CN | disclosed |
| WO-2023214017-A1 | CYCLIC CIDOFOVIR OR A PRODRUG THEREOF FOR USE IN THE TREATMENT OR PREVENTION OF AFRICAN SWINE FEVER | VIROVET NV (BE) | 2023-11-09 | — | — | WO | disclosed |
| WO-2023144163-A1 | A GLUN2D INHIBITOR FOR USE IN THE TREATMENT OR RELAPSE PREVENTION OF A DEPRESSIVE EPISODE | ALBERT-LUDWIGS-UNIVERSITÄT FREIBURG (DE) | 2023-08-03 | — | — | WO | disclosed |
| WO-2023080258-A1 | CARBONYL COMPOUND, METHOD FOR PRODUCING CARBONYL COMPOUND, METHOD FOR PRODUCING ISOCYANATE COMPOUND, AND ISOCYANATE COMPOSITION | 旭化成株式会社 | 2023-05-11 | — | — | WO | disclosed |
| WO-2023080257-A1 | METHOD FOR PRODUCING ISOCYANATE COMPOUNDS, METHOD FOR PRODUCING CARBAMATE COMPOUNDS, METHOD FOR RECOVERING AMINE COMPOUNDS, AND ISOCYANATE COMPOSITION | 旭化成株式会社 | 2023-05-11 | — | — | WO | disclosed |
| EP-4161596-A1 | NANOFIBROUS MATERIAL PARTICULARLY FOR TOPICAL USE IN THERAPIES | Univerzita Karlova (CZ) | 2023-04-12 | — | — | EP | disclosed |
| US-5412118-A | Thickened foam stable compositions comprising alkyl(alkyl glycosid)uronamides | LEVER BROTHERS COMPANY, DIVISION OF CONOPCO, INC. (US) | 1995-05-02 | — | — | US | disclosed |
| EP-0612777-A2 | Thermosetting molding and expansion-forming compositions | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1994-08-31 | — | — | EP | disclosed |
| EP-0612797-A2 | Modification method of resins | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1994-08-31 | — | — | EP | disclosed |
| WO-1994012511-A1 | ALDONAMIDES AND THEIR USE AS SURFACTANTS | UNILEVER PLC (GB) | 1994-06-09 | — | — | WO | disclosed |
| EP-0313083-A2 | Silver halide color photographic material | FUJI PHOTO FILM CO., LTD. (JP) | 1989-04-26 | — | — | EP | disclosed |
| EP-0301477-A2 | Silver halide color photosensitive material and method of processing thereof | Fuji Photo Film Co., Ltd. (JP) | 1989-02-01 | — | — | EP | disclosed |
| EP-0059383-A1 | Improver for the color fastness of dyed cotton textiles to chlorinated water and process for improving the color fastness of dyed cotton textiles to chlorinated water | Dainippon Pharmaceutical Co., Ltd. (JP) | 1982-09-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11135237-B2 | Lipophosphonoxins of second generation, and their use | PLA2G1B, PLA2G2E, PLA2G4C | THRB 2528/4885TSHR 1768/4885MEN1 1905/4885 |
| US-20210220383-A1 | LIPOPHOSPHONOXINS OF SECOND GENERATION, AND THEIR USE | PLA2G1B, PLA2G2E, PLA2G4C | THRB 2528/4885TSHR 1768/4885MEN1 1905/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.